IM Cannabis Corp.
No SEC Form 4 filings for $IMCC in the last 30 days.
See all $IMCC insider activity →IM Cannabis Corp. (IMCC) raised US$225,000 through a convertible note financing with an institutional investor. The note bears 8% interest, convertible into common shares at a fixed or market-based price. Proceeds will be used for general corporate purposes. The company also issued warrants for 77,855 shares. IMCC operates in Israel and Germany, with plans to sell its German operations.
IM Cannabis Corp. (IMCC) plans a 30:1 share consolidation by September 15, 2026, to meet Nasdaq's $1.00 minimum bid price requirement. The company expects 603,922 shares post-consolidation, with trading to resume on August 27, 2026. The move aims to regain compliance with Nasdaq's listing rules.
IM Cannabis (IMCC) agreed to sell all shares of its subsidiary I.M.C. Holdings Ltd., holding European-focused assets, to Slil.com Holding Ltd. under a definitive share purchase agreement. The deal includes Slil acknowledging prior C$3.0M advances and assuming liabilities up to C$9.4M, with about C$10.0M intercompany debt repaid. Pro forma liabilities fall to C$16.0M from C$30.3M; shareholders’ deficit narrows to C$2.6M. Closing is due by Sept. 30, 2026, subject to conditions.
Over the past 7 days, alphai's AI scored 1 news story mentioning IMCC (IM Cannabis Corp.). Coverage has been balanced: 0 bullish, 1 neutral, and 0 bearish.
Recent IMCC coverage spans corporate actions, financial news and earnings.
The modest capital raise provides short‑term liquidity but is unlikely to move the stock significantly.
The reverse split is intended to lift the stock’s per-share price to meet Nasdaq’s $1.00 minimum bid requirement, with trading resuming on a post-consolidation basis Aug. 27, 2026.
The related-party asset sale is designed to cut liabilities and narrow the equity deficit, but it also introduces execution and minority-approval risk under MI 61-101 hardship exemptions.
The earnings release highlights deteriorating profitability and a weaker balance sheet, increasing near-term funding and going-concern risk sensitivity.
Sharp revenue drop and widened losses raise concerns about liquidity and growth prospects.
alphai scores every news story that mentions IMCC with an AI model for sentiment and relevance, and aggregates insider trades from IM Cannabis Corp.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
IM Cannabis Corp. (IMCC) raised US$225,000 through a convertible note financing with an institutional investor. The note bears 8% interest, convertible into common shares at a fixed or market-based price. Proceeds will be used for general corporate purposes. The company also issued warrants for 77,855 shares. IMCC operates in Israel and Germany, with plans to sell its German operations.
1 min readIM Cannabis Corp. (IMCC) plans a 30:1 share consolidation by September 15, 2026, to meet Nasdaq's $1.00 minimum bid price requirement. The company expects 603,922 shares post-consolidation, with trading to resume on August 27, 2026. The move aims to regain compliance with Nasdaq's listing rules.
4 min readIM Cannabis (IMCC) agreed to sell all shares of its subsidiary I.M.C. Holdings Ltd., holding European-focused assets, to Slil.com Holding Ltd. under a definitive share purchase agreement. The deal includes Slil acknowledging prior C$3.0M advances and assuming liabilities up to C$9.4M, with about C$10.0M intercompany debt repaid. Pro forma liabilities fall to C$16.0M from C$30.3M; shareholders’ deficit narrows to C$2.6M. Closing is due by Sept. 30, 2026, subject to conditions.
4 min readIM Cannabis Corp. (Nasdaq: IMCC) reported Q2 2026 and first-half 2026 results. For six months ended June 30, 2026, revenue fell to C$16.3M from C$25.2M, gross profit to C$2.9M from C$6.9M, and net loss to C$6.9M (C$0.85/share). Q2 revenue was C$7.6M, net loss C$4.4M (C$0.47/share). Cash was C$1.6M at June 30, 2026.
4 min readIM Cannabis Corp. (IMCC) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 IM Cannabis Corp. Announces Second Quarter and First Half 2026 Financial Results TORONTO and GLIL YAM, Israel, August 13, 2026 /PRNewswire/ -- IM Cannabis Corp. (" IMC " or the " Company ") (Nasdaq: IMCC), today announced its financial results for the three and six m
2 min readIM Cannabis Corp. (Nasdaq: IMCC) said it closed a US$250,000 convertible note private placement with an institutional investor. The note issued Aug. 6, 2026 carries 8% interest, rising to 14% on default, and converts into common shares at the lower of US$0.122 or 90% of prior 20-day VWAP (floor US$0.02436). It also issued warrants for up to 2,052,545 shares at C$0.17, expiring Aug. 7, 2031.
4 min readIM Cannabis Corp. (Nasdaq: IMCC) said it closed a US$225,000 convertible note private placement with an institutional investor. The note has 8% interest, rising to 14% on default, converts into common shares at the lower of US$0.152 or 90% of prior 20-day VWAP (floor US$0.0303), plus a 4.99% cap. It also issued warrants for up to 1,483,386 shares (C$0.22 exercise) and plans to use proceeds for general corporate purposes.
3 min readIM Cannabis Corp. (Nasdaq: IMCC) said it filed a resale registration statement on Form F-3 with the SEC, following prior releases in May and June 2026. The filing covers 17,276,931 common shares from three convertible promissory notes (US$250k, US$300k, US$225k) and related warrants. The statement is filed but not yet effective; the company will not receive proceeds.
3 min readIM Cannabis Corp. (IMCC.CN) experienced a 40% intraday drop on January 30, 2026, closing at C$5.10 on unusually high volume, indicating potential forced selling followed by short-term buying interest for an oversold bounce. Meyka AI rates IMCC.CN as a "HOLD" with a score of 62.74, suggesting high volatility and recommending careful risk management for traders considering re-entry above C$6.50 with stops at C$4.50. The article outlines technical triggers, valuation metrics, and scenario price targets, including a long-range forecast of C$26.49, emphasizing that these are model projections and not guarantees.
3 min read
